Keywords = Imatinib Mesylate
Number of Articles: 4
1. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients

Volume 22, Issue 2, February 2021, Pages 565-571

Aziati Azwari Annuar; Ravindran Ankathil; Nazihah Mohd Yunus; Azlan Husin; Nur Shafawati Ab Rajab; Ahmad Aizat Abdul Aziz; Mohd Ismail Ibrahim; Sarina Sulong


2. Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role

Volume 20, Issue 12, December 2019, Pages 3689-3695

Ikhwan Rinaldi; Ary Harryanto Reksodiputro; Sri Widia Jusman; Alida Harahap; Rianto Setiabudy; Septelia Inawati Wanandi; Karmel Tambunan; Catharina Suharti